Charles River Laboratories International (CRL) Gains from Investment Securities (2009 - 2025)

Charles River Laboratories International (CRL) has reported Gains from Investment Securities for 17 consecutive years, with $802000.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Gains from Investment Securities rose 116.34% year-over-year to $802000.0; the TTM figure through Dec 2025 stood at -$2.5 million (up 44.95% YoY), while the FY2025 annual figure was -$2.5 million, up 44.95% from the prior year.
• Gains from Investment Securities came in at $802000.0 for Q4 2025 at Charles River Laboratories International, up from -$3.0 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $15.5 million in Q4 2022, with the low at -$36.3 million in Q3 2022.
• Average Gains from Investment Securities over 5 years is -$1.4 million, with a median of $110000.0 recorded in 2022.
• The largest YoY upside for Gains from Investment Securities was 2227.71% in 2022 against a maximum downside of 3816.81% in 2022.
• Year by year, Gains from Investment Securities stood at $664000.0 in 2021, then soared by 2227.71% to $15.5 million in 2022, then slumped by 120.21% to -$3.1 million in 2023, then slumped by 57.12% to -$4.9 million in 2024, then jumped by 116.34% to $802000.0 in 2025.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $802000.0, -$3.0 million, and -$243000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.